Product Research & Development :
Saudi Pharmaceutical Industries views its R&D capabilities as a vital component of its business strategy that will provide a sustainable, long-term competitive advantage. The Company has a pool of formulator engaged in path-breaking research.
SPI to have started its research program in the late 2000's, in support of its global ambitions. A first-of-its-kind world class R&D centre in the SPI premises was commissioned in 2001.
Today, the Company's having multi-disciplinary R&D center in KSA , In-house dedicated facilities for Veterinary and Human Pharmaceutical research and innovative research. The robust R&D environment for the development reflects the Company's commitment to be a leader in the Veterinary pharmaceutical space offering value added formulations based on its research capabilities.
The new drug developing areas at SPI include Human injectable and Veterinary Injectables. Presently, the Company having the new site of the state of the art facility for Human Injectale line will have commenced in very soon, The Company has signed collaborative research programs with Unicare cosmetics.
SPI continues to aggressively pursue its mission to become a Research-based International Pharmaceutical Company.